← FDA Drug Approvals (Drugs@FDA)
OXYBUTYNIN CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2019-02-06
Drug application
- FDA Application #
ANDA211062- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYBUTYNIN CHLORIDE
- Generic name
- Oxybutynin Chloride
- Active ingredients
- OXYBUTYNIN CHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- HIBROW HLTHCARE
- First approval
- 2019-02-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown